{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20090915",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "7055",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022211s000ltr.pdf",
              "date": "20090921",
              "type": "Letter"
            },
            {
              "id": "17092",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022211lbl.pdf",
              "date": "20090921",
              "type": "Label"
            },
            {
              "id": "21959",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211_zirgan_toc.html",
              "date": "20100105",
              "type": "Review"
            },
            {
              "id": "24261",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_SumR.pdf",
              "date": "20100105",
              "type": "Summary Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20140512",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20140226",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20260120",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "84789",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/022211Orig1s007ltr.pdf",
              "date": "20260121",
              "type": "Letter"
            },
            {
              "id": "84799",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022211s007lbl.pdf",
              "date": "20260121",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20140429",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        }
      ],
      "application_number": "NDA022211",
      "sponsor_name": "BAUSCH AND LOMB",
      "openfda": {
        "application_number": [
          "NDA022211"
        ],
        "brand_name": [
          "ZIRGAN"
        ],
        "generic_name": [
          "GANCICLOVIR"
        ],
        "manufacturer_name": [
          "Bausch & Lomb Incorporated"
        ],
        "product_ndc": [
          "24208-535"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "OPHTHALMIC"
        ],
        "substance_name": [
          "GANCICLOVIR"
        ],
        "rxcui": [
          "388052",
          "864650"
        ],
        "spl_id": [
          "52207853-4445-f142-e063-6394a90a281c"
        ],
        "spl_set_id": [
          "ea25e7ac-7a93-4ec8-975b-2cec197e1c27"
        ],
        "package_ndc": [
          "24208-535-35",
          "24208-535-32",
          "24208-535-15"
        ],
        "nui": [
          "N0000175461",
          "N0000020060",
          "N0000175459",
          "N0000175466"
        ],
        "pharm_class_epc": [
          "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
          "Nucleoside Analog Antiviral [EPC]"
        ],
        "pharm_class_moa": [
          "DNA Polymerase Inhibitors [MoA]"
        ],
        "unii": [
          "P9G3CKZ4P5"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ZIRGAN",
          "active_ingredients": [
            {
              "name": "GANCICLOVIR",
              "strength": "0.15%"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "GEL",
          "route": "OPHTHALMIC",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}